BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 29660932)

  • 1. Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.
    Zolezzi JM; Lindsay CB; Serrano FG; Ureta RC; Theoduloz C; Schmeda-Hirschmann G; Inestrosa NC
    J Alzheimers Dis; 2018; 63(2):705-723. PubMed ID: 29660932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid.
    Marsh J; Bagol SH; Williams RSB; Dickson G; Alifragis P
    Neurobiol Dis; 2017 Oct; 106():63-75. PubMed ID: 28647556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.
    Hu WY; He ZY; Yang LJ; Zhang M; Xing D; Xiao ZC
    Br J Pharmacol; 2015 May; 172(9):2273-85. PubMed ID: 25521332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.
    Huang S; Tong H; Lei M; Zhou M; Guo W; Li G; Tang X; Li Z; Mo M; Zhang X; Chen X; Cen L; Wei L; Xiao Y; Li K; Huang Q; Yang X; Liu W; Zhang L; Qu S; Li S; Xu P
    Brain Res; 2018 Jan; 1678():129-137. PubMed ID: 29066369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin.
    Chang L; Cui W; Yang Y; Xu S; Zhou W; Fu H; Hu S; Mak S; Hu J; Wang Q; Ma VP; Choi TC; Ma ED; Tao L; Pang Y; Rowan MJ; Anwyl R; Han Y; Wang Q
    Sci Rep; 2015 Jul; 5():10256. PubMed ID: 26194093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers.
    Vargas JY; Ahumada J; Arrázola MS; Fuenzalida M; Inestrosa NC
    Exp Neurol; 2015 Feb; 264():14-25. PubMed ID: 25450465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticity.
    Zeng Y; Zhao D; Xie CW
    J Alzheimers Dis; 2010; 21(3):823-31. PubMed ID: 20634586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone ameliorated Aβ
    Wu L; Feng X; Li T; Sun B; Khan MZ; He L
    Behav Brain Res; 2017 Mar; 322(Pt A):145-156. PubMed ID: 28093254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.
    Freund RK; Gibson ES; Potter H; Dell'Acqua ML
    Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging Enables Ca2+ Overload and Apoptosis Induced by Amyloid-β Oligomers in Rat Hippocampal Neurons: Neuroprotection by Non-Steroidal Anti-Inflammatory Drugs and R-Flurbiprofen in Aging Neurons.
    Calvo-Rodríguez M; García-Durillo M; Villalobos C; Núñez L
    J Alzheimers Dis; 2016 Jul; 54(1):207-21. PubMed ID: 27447424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cassia obtusifolia seed ameliorates amyloid β-induced synaptic dysfunction through anti-inflammatory and Akt/GSK-3β pathways.
    Yi JH; Park HJ; Lee S; Jung JW; Kim BC; Lee YC; Ryu JH; Kim DH
    J Ethnopharmacol; 2016 Feb; 178():50-7. PubMed ID: 26674159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD).
    Rammes G; Mattusch C; Wulff M; Seeser F; Kreuzer M; Zhu K; Deussing JM; Herms J; Parsons CG
    Neuropharmacology; 2017 Sep; 123():100-115. PubMed ID: 28174113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.